Paper29945573
Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
Molnár B and 13 others. BMC Cancer, 2018. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations. Papers, record 29945573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29945573
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| DNA Methylation | Major topic |
| Exons | Major topic |
| Mutation | Major topic |
| Promoter Regions, Genetic | Major topic |
| Adenoma | |
| CpG Islands | |
| Humans | |
| Long Interspersed Nucleotide Elements | |
| Signal Transduction | |
| Tumor Suppressor Protein p53 |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| KMR-12-1-2012-0216 | National Research, Development and Innovation Office | PubMed | PubMed | ||
| NVKP_16-1-2016-0004 | National Research, Development and Innovation Office | PubMed | PubMed | ||
| NNF15OC0016584 | Novo Nordisk Foundation Interdisciplinary Synergy Programme | PubMed | PubMed | ||
| OTKA-K111743 | Országos Tudományos Kutatási Alapprogramok | OTKAK111743 | PubMed | NIH RePORTER |
References86
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28459462 | Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia. | Oncogene | 2017 | https://conductscience.org/library/papers/28459462 | PubMed |
| 2 | 25220842 | Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. | Int J Cancer | 2015 | https://conductscience.org/library/papers/25220842 | PubMed |
| 3 | 23747112 | Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. | J Mol Diagn | 2013 | https://conductscience.org/library/papers/23747112 | PubMed |
| 4 | 23896626 | Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia. | Prostate Cancer Prostatic Dis | 2013 | https://conductscience.org/library/papers/23896626 | PubMed |
| 5 | 22363125 | Identification of differential gene expressions in colorectal cancer and polyp by cDNA microarray. | World J Gastroenterol | 2012 | https://conductscience.org/library/papers/22363125 | PubMed |
| 6 | 26482909 | Genome-wide DNA methylation detection by MethylCap-seq and Infinium HumanMethylation450 BeadChips: an independent large-scale comparison. | Sci Rep | 2015 | https://conductscience.org/library/papers/26482909 | PubMed |
| 7 | 17317818 | A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17317818 | PubMed |
| 8 | 27916892 | Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27916892 | PubMed |
| 9 | 21659424 | Genome-scale analysis of aberrant DNA methylation in colorectal cancer. | Genome Res | 2012 | https://conductscience.org/library/papers/21659424 | PubMed |
| 10 | 24260063 | DNA methylation as an epigenetic biomarker in colorectal cancer. | Oncol Lett | 2013 | https://conductscience.org/library/papers/24260063 | PubMed |
| 11 | 25139296 | Analysis of DNA methylation in bowel lavage fluid for detection of colorectal cancer. | Cancer Prev Res (Phila) | 2014 | https://conductscience.org/library/papers/25139296 | PubMed |
| 12 | 22388286 | Fast gapped-read alignment with Bowtie 2. | Nat Methods | 2012 | https://conductscience.org/library/papers/22388286 | PubMed |
| 13 | 28753106 | Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples. | Epigenetics | 2017 | https://conductscience.org/library/papers/28753106 | PubMed |
| 14 | 28035578 | The BAX gene as a candidate for negative autophagy-related genes regulator on mRNA levels in colorectal cancer. | Med Oncol | 2017 | https://conductscience.org/library/papers/28035578 | PubMed |
| 15 | 6262918 | 5-Methylcytosine in eukaryotic DNA. | Science | 1981 | https://conductscience.org/library/papers/6262918 | PubMed |
| 16 | 27978560 | Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. | JAMA Oncol | 2017 | https://conductscience.org/library/papers/27978560 | PubMed |
| 17 | 21699707 | A genome-wide DNA methylation study in colorectal carcinoma. | BMC Med Genomics | 2011 | https://conductscience.org/library/papers/21699707 | PubMed |
| 18 | 24485021 | A panel of genes methylated with high frequency in colorectal cancer. | BMC Cancer | 2014 | https://conductscience.org/library/papers/24485021 | PubMed |
| 19 | 25973791 | Identification of Sestrin3 Involved in the In vitro Resistance of Colorectal Cancer Cells to Irinotecan. | PLoS One | 2015 | https://conductscience.org/library/papers/25973791 | PubMed |
| 20 | 16172211 | Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk. | Cancer Epidemiol Biomarkers Prev | 2005 | https://conductscience.org/library/papers/16172211 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42389235 | Uncovering alterations in cancer epigenetics via trans-dimensional Markov chain Monte Carlo and hidden Markov models. | J R Stat Soc Ser C Appl Stat | 2026 | https://conductscience.org/library/papers/42389235 | PubMed |
| 42074302 | Bidirectional Interactions Between Immune Regulation and the Insulin-like Growth Factor Axis in Colorectal Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074302 | PubMed |
| 41954995 | CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer. | Oncotarget | 2026 | https://conductscience.org/library/papers/41954995 | PubMed |
| 41931180 | Functional roles and clinical potential of SOX1 in cancer as a biomarker and therapeutic target. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41931180 | PubMed |
| 41438082 | Regulatory role of phosphatidylcholine metabolic reprogramming in colorectal cancer progression and neutrophil interactions. | iScience | 2025 | https://conductscience.org/library/papers/41438082 | PubMed |
| 41001838 | Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/41001838 | PubMed |
| 40148827 | Analysis of extracellular vesicles of frequently used colorectal cancer cell lines. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40148827 | PubMed |
| 40004106 | Integrated Analysis of Somatic DNA Variants and DNA Methylation of Tumor Suppressor Genes in Colorectal Cancer. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40004106 | PubMed |
| 39598359 | Increased MAGE-C Family Gene Expression Levels as a Biomarker of Colon Cancer Through the Demethylation Mechanism. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39598359 | PubMed |
| 38720389 | IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p. | J Transl Med | 2024 | https://conductscience.org/library/papers/38720389 | PubMed |
| 38302914 | Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma. | BMC Gastroenterol | 2024 | https://conductscience.org/library/papers/38302914 | PubMed |
| 37876440 | Syndecan-2 modulates the YAP pathway in epithelial-to-mesenchymal transition-related migration, invasion, and drug resistance in colorectal cancer. | Heliyon | 2023 | https://conductscience.org/library/papers/37876440 | PubMed |
| 37408248 | The Role of FBXW7 in Gynecologic Malignancies. | Cells | 2023 | https://conductscience.org/library/papers/37408248 | PubMed |
| 37366899 | High-LET-Radiation-Induced Persistent DNA Damage Response Signaling and Gastrointestinal Cancer Development. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37366899 | PubMed |
| 37242540 | MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37242540 | PubMed |
| 36631756 | Identification and clinical validation of key genes as the potential biomarkers in colorectal adenoma. | BMC Cancer | 2023 | https://conductscience.org/library/papers/36631756 | PubMed |
| 36612042 | A Race-Specific, DNA Methylation Analysis of Aging in Normal Rectum: Implications for the Biology of Aging and Its Relationship to Rectal Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36612042 | PubMed |
| 36483329 | IL1RN and PRRX1 as a Prognostic Biomarker Correlated with Immune Infiltrates in Colorectal Cancer: Evidence from Bioinformatic Analysis. | Int J Genomics | 2022 | https://conductscience.org/library/papers/36483329 | PubMed |
| 36087301 | The DNAm levels of CREB5 (cg11301281) were associated with clopidogrel resistance. | J Clin Lab Anal | 2022 | https://conductscience.org/library/papers/36087301 | PubMed |
| 35550030 | CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies. | Elife | 2022 | https://conductscience.org/library/papers/35550030 | PubMed |
Genes72
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29945573
GET https://conductscience.org/api/papers/v1/29945573/references?page=2